Detailed Information on Publication Record
2007
Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results.
WOZNICOVÁ, Vladana and Zuzana VALIŠOVÁBasic information
Original name
Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results.
Name in Czech
Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results.
Authors
WOZNICOVÁ, Vladana (203 Czech Republic, guarantor) and Zuzana VALIŠOVÁ (203 Czech Republic)
Edition
Journal of Clinical Microbiology, 2007, 0095-1137
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30216 Dermatology and venereal diseases
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.708
RIV identification code
RIV/00216224:14110/07:00028188
Organization unit
Faculty of Medicine
UT WoS
000247286500020
Keywords (in Czech)
syfilis; diagnostika; ELISA; sérologie
Keywords in English
syphilis; diagnostics; ELISA; serology
Tags
Změněno: 25/6/2009 14:25, doc. MUDr. Vladana Woznicová, Ph.D.
V originále
Using the Captia Select Syph-G enzyme-linked immunosorbent assay (ELISA), we analyzed the sera of 1,771 patients from a high-risk population attending sexually transmitted disease (STD) clinics. We conclude that the Captia SelectSyph-G ELISA is a reliable tool for syphilis testing in a high-risk population and recommend the utilization of the Captia SelectSyph-G ELISA as a confirmatory test in at-risk patients.
In Czech
Using the Captia Select Syph-G enzyme-linked immunosorbent assay (ELISA), we analyzed the sera of 1,771 patients from a high-risk population attending sexually transmitted disease (STD) clinics. We conclude that the Captia SelectSyph-G ELISA is a reliable tool for syphilis testing in a high-risk population and recommend the utilization of the Captia SelectSyph-G ELISA as a confirmatory test in at-risk patients.
Links
NR8967, research and development project |
|